Yahoo Finance Why QuantumScape, Freyr, and Plug Power Stocks Just Dropped
EV investors are nervous today, but one thing they need not worry about: Plug Power won't deliver bad news tonight.
EV investors are nervous today, but one thing they need not worry about: Plug Power won't deliver bad news tonight.
Regional banks have steadily increased the interest rates they offer on deposit accounts to retain customers looking for greater returns by parking their money in higher-yielding alternatives. Cincinnati, Ohio-based Fifth Third's net interest income on a reported basis - the difference between what a bank earns on loans and pays on deposits - fell nearly 8.8% to $1.38 billion in the quarter. Fifth Third continues to expect its NII in 2024 to decline between 2% and 4%.
"Maybe I’m too old now, maybe I’m not..."
Pop singer is known to delve into themes of love and heartbreak with her songwriting
Futures initially tumbled overnight, but slashed losses as Israel's attack on Iran seemed limited. The market power trend is about to end. Netflix gave weak guidance.
Rijkaard Salu Siafa’s death has ‘has ripped an irreparable hole’ in his family, police say
Exclusive: The €5 ticket scheme aims ‘to safeguard the city from overtourism’ says leading city official,
Celtic legend John Hartson revealed Scottish Gas Scottish Cup victory with the Hoops is his favourite football memory.
TORONTO, April 19, 2024 (GLOBE NEWSWIRE) -- Silver Mountain Resources Inc. (TSXV: AGMR) (OTCQB: AGMRF) ("Silver Mountain" or the "Company"), is pleased to announce that it has upsized its previously announced public offering (the "Offering") of units (the "Units") to up to $9,000,035 from $7,502,000, at a price of $0.11 per Unit. If the Over-Allotment Option (as defined below) is exercised in full, the aggregate gross proceeds of the Offering will be approximately $10,350,040. Each Unit is compr
For decades, a Social Security spousal rule has allowed recipients to switch between their benefits and their spouse's to receive the maximum amount. That rule is scheduled to end this year for...
Friday’s action assessed
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” first quarter 2024 investor letter. A copy of the same can be downloaded here. The US stock market started 2024 optimistically. In the first quarter, the fund returned 8.29% (gross) and 8.09% (net) compared to 11.41% for the Russell 1000 Growth Index and […]
Music video features North Koreans of different backgrounds belting out lines such as: ‘Let’s brag about Kim Jong-un, a friendly father’
Two US officials claim an Israeli missile struck Iran near the city of Isfahan overnight - although Iran has downplayed reports as Israel remained silent
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "Natural Killer (NK) cell therapy - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Natural Killer (NK) cell therapy - Pipeline Insight, 2024," report provides comprehensive insights about 100+ companies and 185+ pipeline drugs in Natural Killer (NK) cell therapy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutic
Jennifer Lopez attended the Hispanic Federation's annual gala wearing a Monique Lhuillier nude strapless ruched gown with a hip-high leg slit and matching cape.
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:VELAY FINANCIAL SERVICES LTD(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.Not applicable(c) Name of
ClearPoint Neuro, Inc. ( NASDAQ:CLPT ), might not be a large cap stock, but it saw significant share price movement...
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "AAV vectors in gene therapy - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This "AAV vectors in gene therapy - Pipeline Insight, 2024 report provides comprehensive insights about 70+ companies and 235+ pipeline drugs in AAV vectors in gene therapy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by pro